Raymond Townsend, Director at Kindred Biosciences, Inc. (KIN), bought 1,677 shares at $5.85 ($10K) on 2015-08-31, disclosed to the SEC on 2015-09-01.
Open-market purchase of $10k KIN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.85 | 2 | $12 | 0.1% |
| 2 | $5.85 | 1,675 | $10K | 99.9% |
| Total | $5.85 avg | 1,677 | $10K | 100% |
| Filing → |
| KIN | SELL | 2018-03-14 | $860 | — | Filing → |
| KIN | SELL | 2018-01-04 | $121K | — | Filing → |
| KIN | BUY | 2015-11-24 | $8K | — | Filing → |